Nitinotes, developer of EndoZip™, a fully automated endoscopic suturing system aimed at treating obesity, today announced that clinical research on the EndoZip™ system will be presented at upcoming ...

REDWOOD CITY, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced ...

Dr. Surbhi Sidana discussed the topic of minimal residual disease during the CURE Educated Patient® Multiple Myeloma Summit.

PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) has announced its financial results for the fourth quarter and full ...

Q4 2024 Earnings Call Transcript April 1, 2025 Operator: Good afternoon ladies and gentlemen and thank you for standing by.

ZOLAR is a first-in-human, proof-of-concept and biodistribution trial that uses positron emission tomography (PET) to evaluate olaratumab, a monoclonal antibody, as a therapeutic radiopharmaceutical ...

Verified Market Research®, a leading provider of business intelligence and market analysis is thrilled to announce the ...

The former IES and NCES leader speaks candidly about radical cuts to the Education Department, government ‘stasis’ and the uncertain future of NAEP.

We are excited to welcome Dr. Vincent, whose extensive drug development experience and expertise in translating groundbreaking science into therapies will be instrumental in leading our scientific ...

Queen Letizia of Spain brought warm, springtime hues to her latest royal outing on Tuesday in Granada. The Spanish royal ...

There is no shortage of myths about the cancellation of US foreign assistance. These include the widely held misconception ...